| Literature DB >> 10226677 |
Abstract
Keywords: Americas; Biology; Bleeding; Breast Cancer; Breast Feeding; Cancer; Cardiovascular Effects; Cervical Cancer; Contraception; Contraception Failure; Contraceptive Agents, Female--contraindications; Contraceptive Agents, Female--pharmacodynamics; Contraceptive Agents, Female--side effects; Contraceptive Agents, Progestin--contraindications; Contraceptive Agents, Progestin--pharmacodynamics; Contraceptive Agents, Progestin--side effects; Contraceptive Agents--contraindications; Contraceptive Agents--pharmacodynamics; Contraceptive Agents--side effects; Contraceptive Effectiveness; Contraceptive Methods; Contraceptive Mode Of Action; Contraceptive Usage; Developed Countries; Diseases; Drug Interactions; Drugs; Endometrial Cancer; Family Planning; Genitalia; Genitalia, Female; Health; Infant Nutrition; Infections; Metabolic Effects; Neoplasms; Norethindrone; Norgestrel; North America; Northern America; Nutrition; Oral Contraceptives; Ovarian Cancer; Ovarian Effects; Ovary; Physiology; Progestins, Low-dose--contraindications; Progestins, Low-dose--pharmacodynamics; Progestins, Low-dose--side effects; Reproductive Tract Infections; Signs And Symptoms; Treatment; United States; Urogenital System; Uterine Effects; Uterus; Vaginal Abnormalities
Mesh：
Substances：
Year: 1994 PMID： 10226677
Source DB: PubMed Journal: Contraception ISSN： 0010-7824 Impact factor: 3.375